This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
Nontuberculous Mycobacteria (NTM–MAC) and Aspergillosis
March 10, 2026
Asthma and Aspergillosis
March 9, 2026
Weekly Aspergillosis Research Update – Week 10, 2026
March 9, 2026
Bronchiectasis in Aspergillosis Patients
March 6, 2026
Damp & Mould Health Evidence Monitor: 4 March 2026
March 4, 2026
Weeks 6–7 Aspergillosis Literature Update
March 3, 2026
Watch the World Aspergillosis Day 2026 talks
March 2, 2026
Using AI Safely When You Have Aspergillosis
March 2, 2026
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
